[
    [
        {
            "time": "2021-07-02",
            "original_text": "抗肿瘤药新政搅动市场：新药研发难度加大，同质化竞争受抑制，CRO成长逻辑被削弱？",
            "features": {
                "keywords": [
                    "抗肿瘤药",
                    "新政",
                    "新药研发",
                    "CRO"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "抗肿瘤药新政搅动市场：新药研发难度加大，同质化竞争受抑制，CRO成长逻辑被削弱？",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-03",
            "original_text": "为创新带来颠覆性的方案和价值 | 对话泰格医药西欧和非洲负责人James Brook",
            "features": {
                "keywords": [
                    "创新",
                    "泰格医药",
                    "对话",
                    "西欧",
                    "非洲"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "为创新带来颠覆性的方案和价值 | 对话泰格医药西欧和非洲负责人James Brook",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-04",
            "original_text": "里昂：料药明生物(2269.HK)及泰格医药(3347.HK)可受惠新措施",
            "features": {
                "keywords": [
                    "里昂",
                    "药明生物",
                    "泰格医药",
                    "新措施"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "里昂：料药明生物(2269.HK)及泰格医药(3347.HK)可受惠新措施",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-05",
            "original_text": "医药：CDE临床研发指导原则驱动新药研发规范化发展",
            "features": {
                "keywords": [
                    "医药",
                    "CDE",
                    "临床研发",
                    "指导原则"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药：CDE临床研发指导原则驱动新药研发规范化发展",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-06",
            "original_text": "高瓴资本概念股涨势强劲，恩捷股份再创新高",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "恩捷股份"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "新能源"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股涨势强劲，恩捷股份再创新高",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-07",
            "original_text": "医药股猛跌主题基金齐挫，行情结束了么？",
            "features": {
                "keywords": [
                    "医药股",
                    "猛跌",
                    "主题基金"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药股猛跌主题基金齐挫，行情结束了么？",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-08",
            "original_text": "策略日报：指数尾盘拉升 科技、医药板块回落",
            "features": {
                "keywords": [
                    "指数",
                    "尾盘拉升",
                    "科技",
                    "医药板块"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "策略日报：指数尾盘拉升 科技、医药板块回落",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-09",
            "original_text": "【异动股】泰格医药(03347.HK)涨3.2%",
            "features": {
                "keywords": [
                    "异动股",
                    "泰格医药"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】泰格医药(03347.HK)涨3.2%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2021-07-10",
            "original_text": "CDE新政引发CRO公司暴跌？真实内因或许是...",
            "features": {
                "keywords": [
                    "CDE",
                    "新政",
                    "CRO",
                    "暴跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "CDE新政引发CRO公司暴跌？真实内因或许是...",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-11",
            "original_text": "医药外包概念股集体重挫 创新药马太效应料加剧",
            "features": {
                "keywords": [
                    "医药外包",
                    "概念",
                    "重挫",
                    "创新药",
                    "马太效应"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药外包概念股集体重挫 创新药马太效应料加剧",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-12",
            "original_text": "每日财经观察：中办国办发布意见，依法从严打击证券违法活动",
            "features": {
                "keywords": [
                    "中办国办",
                    "意见",
                    "证券违法活动"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "证券"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "每日财经观察：中办国办发布意见，依法从严打击证券违法活动",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-13",
            "original_text": "港股盘前必读：香港交易所将推出全新招股平台FINI以全面简化IPO程序",
            "features": {
                "keywords": [
                    "港股",
                    "香港交易所",
                    "FINI",
                    "IPO程序"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "证券"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "港股盘前必读：香港交易所将推出全新招股平台FINI以全面简化IPO程序",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]